As shown in Supplementary Tables 1A–C, we found that only β-defensin 1, DEFB1, expression was consistently and significantly downregulated in liver cancer specimens compared to non-tumor specimens, but not that of other β-defensin genes. The gene discussed is DEFB1; the disease is neoplasm.